UCB
The National Market Access Lead at UCB drives Health Technology Appraisal (HTA) and Pricing & Reimbursement strategies for UK and Ireland markets. This role involves leading submissions to bodies like NICE and SMC, collaborating with cross-functional teams, and building strategic stakeholder relationships to ensure patient access. The position requires deep knowledge of health economics, scientific writing, and the UK healthcare policy environment.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
33% below the average for this role
Senior Market Access Manager - 12 Month Fixed Term Contract
Takeda Pharmaceutical Company Limited
Senior Consultant HTA for the UK market - Johannesburg area - South Africa
IQVIA
Analyst - HE/HTA Specialist for the UK market - Portugal (Hybrid/Home-based)
IQVIA
National Value and Market Access Manager
Alfasigma
Health Economics Manager
Eli Lilly and Company
Senior Consultant HTA for the UK market - Greece (hybrid/home-based)
IQVIA